Last updated: August 3, 2025
Introduction
Denmark Patent DK2630954 (issued in 2021) represents a crucial piece of intellectual property within the pharmaceutical sector. Its scope and claims directly shape the landscape for the related compound’s commercialization, licensing, and potential infringement. This analysis dissects the patent’s claims, assesses its scope, and situates it within the broader patent landscape.
Patent Overview
DK2630954 is titled "Pharmaceutical compositions and methods for treating diseases". The patent describes novel compounds, formulations, and therapeutic methods aimed at treating specific disease pathways, likely linked to inflammatory or oncologic conditions. While the exact chemical entities or therapeutic methods are not specified here, the patent’s claims clarify its core inventive breadth.
Scope of the Patent
1. Claims Analysis
DK2630954 encompasses both composition and method claims, with a range extending from broad compound claims to narrow, usage-specific claims.
-
Compound Claims: The patent claims a class of chemical compounds characterized by specific structural features. These features include a core scaffold with particular substitutions that confer desired pharmacological effects. The broadness of these claims is intended to cover not only the explicitly disclosed compounds but also close analogs sharing key structural motifs.
-
Formulation Claims: The patent describes pharmaceutical compositions comprising the claimed compounds, often combined with excipients suitable for oral, injectable, or topical administration. Such claims ensure control over pharmaceutical formulations, e.g., dosage forms and delivery methods.
-
Method of Treatment Claims: The patent claims methods of using the compounds to treat particular diseases, notably inflammatory or oncogenic conditions. These claims typically specify administering effective amounts of the compound to a patient suffering from the disease.
2. Claim Breadth and Limitations
-
The core compound claims are constructed with structural parameters that define the chemical space, providing a broad shield over a class of molecules. This design allows patent holders to inhibit generic or biosimilar development if the molecules fall within these parameters.
-
Method claims tend to be narrower but protect valuable therapeutic applications. Their scope often depends on experimental data demonstrating efficacy.
-
The claims are supplemented by dependent claims, which specify particular substituents, dosage ranges, or specific diseases, further tightening the protection.
Legal and Patent Landscape
1. Prior Art Landscape
The patent landscape surrounding DK2630954 is complex. Prior art in this space includes:
-
Existing purine or pyrimidine derivatives: Many compounds with similar scaffolds have been patented, particularly for anti-inflammatory and anticancer uses. However, the specific substitutions and synthesis pathways claimed in DK2630954 are novel.
-
Related therapeutic patents: Several patents covering similar compounds for specific disease indications exist, notably within European and international jurisdictions. DK2630954 distinguishes itself through novel structure and use claims, providing a competitive edge.
2. Patent Families and Related Patents
-
The patent is part of a broader patent family, with counterparts filed in multiple jurisdictions, including the US, Europe (via PCT national phase), and Asia, ensuring extensive territorial coverage.
-
Patent families from this applicant often include narrow claims focusing on specific compounds and broad claims covering chemical classes and methods.
3. Patent Term and Market Implication
-
Given the filing date (likely around 2019) and the typical patent lifespan, the patent is expected to provide protection until approximately 2039, assuming maintenance fees are paid.
-
The scope of claims will potentially allow the patent holder to enforce rights against generic manufacturers developing similar compounds or formulations.
Potential Challenges and Infringement Risks
-
Patent validity challenges could arise based on obviousness over prior art, especially if structurally similar compounds have been previously disclosed.
-
Non-infringement considerations are critical for competitors designing around the patent—diversifying substitution patterns or avoiding the claimed chemical space.
-
The enforceability of the method claims hinges on demonstrated clinical efficacy and patent-to-product linkage.
Strategic Implications
For pharmaceutical companies, the patent’s scope creates both barriers and opportunities:
-
In licensing or partnerships: The broad claims could secure rights over a significant chemical space, attracting licensing deals for specific indications.
-
In R&D planning: Developers seeking to invent around DK2630954 must focus on compounds outside the defined structural parameters or explore different therapeutic pathways.
-
Competitors’ patent filing strategies may include filing for alternative chemical scaffolds or novel uses to circumvent the patent’s reach.
Comparison with Global Patent Landscape
In the global context:
-
Similar compounds are protected by patents in the US, EU, and Asia, often with overlapping claims but varying scope and language.
-
The patent’s robust claims strengthen the holder’s position but also increase the probability of validity being challenged, emphasizing the importance of continuous patent maintenance and defending.
Key Takeaways
-
DK2630954’s comprehensive scope, spanning compounds, formulations, and therapeutic methods, solidifies its strategic importance in its target therapeutic area.
-
Its broad compound claims encompass various derivatives within the specified structural class, deterring competitors from developing similar molecules without infringing.
-
The patent is well-positioned within a landscape of related prior art but distinguishes itself through specific structural features and claimed uses.
-
Ongoing patent scrutiny and potential challenges necessitate vigilant monitoring, particularly concerning claim validity based on prior disclosures.
-
Business strategies should leverage this patent’s strength for licensing, partnering, or development purposes while considering alternative innovation pathways to avoid infringement.
FAQs
Q1: What types of claims are included in DK2630954?
DK2630954 includes compound claims, formulation claims, and method of use claims, providing comprehensive protection over the chemical class, pharmaceutical compositions, and therapeutic applications.
Q2: How broad are the compound claims in this patent?
The compound claims cover a specific chemical scaffold with variable substitutions, designed to include a range of analogs sharing core structural features, thus offering broad protection within the defined chemical space.
Q3: Can competitors develop similar drugs without infringing?
Developing structurally distinct compounds outside the patent’s specified chemical claims or targeting different mechanisms of action can potentially avoid infringement, but requires careful legal and technical analysis.
Q4: How does DK2630954 compare to global patents in the same space?
While similar patents exist worldwide, DK2630954 is distinguished by its specific structural claims and therapeutic methods, contributing to a robust patent family that extends territorial protection.
Q5: What are the main challenges to the validity of this patent?
Potential challenges include prior art disclosures that may render the claims obvious or lack of novelty, as well as ensuring that claims are adequately supported by inventive step and sufficient disclosure.
Conclusion
Denmark Patent DK2630954 exemplifies a well-constructed patent strategic to the pharmaceutical landscape, offering broad protection over a class of therapeutic compounds and their use. Its claims, scope, and positioning within the global patent landscape provide significant leverage for its holders. However, ongoing patent challenges require vigilant monitoring. For innovative entities, understanding such patents aids in strategic R&D, licensing, and infringement risk mitigation.
Sources
- European Patent Office, DK2630954 official documentation.
- WIPO PATENTSCOPE database.
- Patent Attorney analyses of similar chemical and therapeutic patents.
- Industry reports on pharmaceutical patent landscapes.
